Literature DB >> 10196215

The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain.

K O Netzer1, A Leinonen, A Boutaud, D B Borza, P Todd, S Gunwar, J P Langeveld, B G Hudson.   

Abstract

The Goodpasture (GP) autoantigen has been identified as the alpha3(IV) collagen chain, one of six homologous chains designated alpha1-alpha6 that comprise type IV collagen (Hudson, B. G., Reeders, S. T., and Tryggvason, K. (1993) J. Biol. Chem. 268, 26033-26036). In this study, chimeric proteins were used to map the location of the major conformational, disulfide bond-dependent GP autoepitope(s) that has been previously localized to the noncollagenous (NC1) domain of alpha3(IV) chain. Fourteen alpha1/alpha3 NC1 chimeras were constructed by substituting one or more short sequences of alpha3(IV)NC1 at the corresponding positions in the non-immunoreactive alpha1(IV)NC1 domain and expressed in mammalian cells for proper folding. The interaction between the chimeras and eight GP sera was assessed by both direct and inhibition enzyme-linked immunosorbent assay. Two chimeras, C2 containing residues 17-31 of alpha3(IV)NC1 and C6 containing residues 127-141 of alpha3(IV)NC1, bound autoantibodies, as did combination chimeras containing these regions. The epitope(s) that encompasses these sequences is immunodominant, showing strong reactivity with all GP sera and accounting for 50-90% of the autoantibody reactivity toward alpha3(IV)NC1. The conformational nature of the epitope(s) in the C2 and C6 chimeras was established by reduction of the disulfide bonds and by PEPSCAN analysis of overlapping 12-mer peptides derived from alpha1- and alpha3(IV)NC1 sequences. The amino acid sequences 17-31 and 127-141 in alpha3(IV)NC1 have thus been shown to contain the critical residues of one or two disulfide bond-dependent conformational autoepitopes that bind GP autoantibodies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196215     DOI: 10.1074/jbc.274.16.11267

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Murine membranous nephropathy: immunization with α3(IV) collagen fragment induces subepithelial immune complexes and FcγR-independent nephrotic syndrome.

Authors:  Jun-Jun Zhang; Mahdi Malekpour; Wentian Luo; Linna Ge; Florina Olaru; Xu-Ping Wang; Maimouna Bah; Yoshikazu Sado; Laurence Heidet; Sandra Kleinau; Agnes B Fogo; Dorin-Bogdan Borza
Journal:  J Immunol       Date:  2012-02-27       Impact factor: 5.422

2.  Genetic elimination of α3(IV) collagen fails to rescue anti-collagen B cells.

Authors:  Amy G Clark; Katherine M Mackin; Mary H Foster
Journal:  Immunol Lett       Date:  2011-09-24       Impact factor: 3.685

3.  Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.

Authors:  Vadim Pedchenko; Olga Bondar; Agnes B Fogo; Roberto Vanacore; Paul Voziyan; A Richard Kitching; Jörgen Wieslander; Clifford Kashtan; Dorin-Bogdan Borza; Eric G Neilson; Curtis B Wilson; Billy G Hudson
Journal:  N Engl J Med       Date:  2010-07-22       Impact factor: 91.245

4.  Basement membrane collagen IV: Isolation of functional domains.

Authors:  Sergei P Boudko; Neonila Danylevych; Billy G Hudson; Vadim K Pedchenko
Journal:  Methods Cell Biol       Date:  2017-11-06       Impact factor: 1.441

Review 5.  Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.

Authors:  J Des Parkin; James D San Antonio; Vadim Pedchenko; Billy Hudson; Shane T Jensen; Judy Savige
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

6.  Identification of a nephritogenic immunodominant B and T cell epitope in experimental autoimmune glomerulonephritis.

Authors:  J Reynolds; J Haxby; J K Juggapah; D J Evans; C D Pusey
Journal:  Clin Exp Immunol       Date:  2008-11-25       Impact factor: 4.330

Review 7.  Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells.

Authors:  Yohei Maeshima
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

Review 8.  Goodpasture's disease: molecular architecture of the autoantigen provides clues to etiology and pathogenesis.

Authors:  Vadim Pedchenko; Roberto Vanacore; Billy Hudson
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-05       Impact factor: 2.894

9.  Modeling of human anti-GBM antibody-alpha3(IV)NC1 interactions predicts antigenic cross-linking through contact of both heavy chains with repeating epitopes on alpha3(IV)NC1.

Authors:  Kevin E C Meyers; Mette Christensen; Michael P Madaio
Journal:  Am J Nephrol       Date:  2009-09-28       Impact factor: 3.754

10.  Novel targets for immunotherapy in glomerulonephritis.

Authors:  Mary H Foster
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.